Stevanato Group (STVN) Competitors €22.62 -0.39 (-1.69%) As of 09/2/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STVN vs. PHG, ZBH, SNN, SOLV, PEN, GKOS, IRTC, BLCO, TMDX, and SLNOShould you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Glaukos (GKOS), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Stevanato Group vs. Its Competitors Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra Glaukos iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Stevanato Group (NYSE:STVN) and Koninklijke Philips (NYSE:PHG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings. Which has higher earnings and valuation, STVN or PHG? Stevanato Group has higher earnings, but lower revenue than Koninklijke Philips. Stevanato Group is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group€1.19B5.73€127.45M€0.5441.89Koninklijke Philips$19.50B1.34-$758.55M$0.19142.73 Is STVN or PHG more profitable? Stevanato Group has a net margin of 11.73% compared to Koninklijke Philips' net margin of 1.00%. Koninklijke Philips' return on equity of 11.95% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.73% 10.34% 6.21% Koninklijke Philips 1.00%11.95%4.94% Do analysts rate STVN or PHG? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83Koninklijke Philips 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in STVN or PHG? 13.7% of Koninklijke Philips shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, STVN or PHG? Stevanato Group has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Does the media favor STVN or PHG? In the previous week, Koninklijke Philips had 2 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for Koninklijke Philips and 6 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.36 beat Koninklijke Philips' score of 1.30 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryStevanato Group and Koninklijke Philips tied by winning 7 of the 14 factors compared between the two stocks. Get Stevanato Group News Delivered to You Automatically Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STVN vs. The Competition Export to ExcelMetricStevanato GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap€6.85B€2.82B€5.77B€21.38BDividend YieldN/A48.51%6.66%3.49%P/E Ratio41.8922.6983.0529.02Price / Sales5.73717.84527.2348.80Price / Cash30.4826.3325.7018.29Price / Book4.326.8111.005.30Net Income€127.45M€32.94M€3.28B€997.87M7 Day Performance1.25%0.08%-0.19%-0.47%1 Month Performance-10.02%7.31%8.33%6.49%1 Year Performance3.10%0.18%53.31%13.66% Stevanato Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STVNStevanato GroupN/A€22.62-1.7%N/A+3.4%€6.85B€1.19B41.895,521Positive NewsPHGKoninklijke Philips3.4736 of 5 stars$27.59+0.0%N/A-10.4%$26.56B$19.50B145.1866,678Positive NewsShort Interest ↑ZBHZimmer Biomet4.4978 of 5 stars$106.11+1.0%$111.44+5.0%-9.0%$21.02B$7.68B25.8217,000Positive NewsDividend AnnouncementAnalyst RevisionSNNSmith & Nephew SNATS2.7954 of 5 stars$37.47+0.7%$36.00-3.9%+19.6%$16.40B$5.81B17.3517,349News CoveragePositive NewsSOLVSolventum2.2687 of 5 stars$73.15+0.7%$85.75+17.2%+12.0%$12.67B$8.25B33.8622,000Positive NewsAnalyst UpgradePENPenumbra4.8277 of 5 stars$272.96+0.5%$300.47+10.1%+33.3%$10.63B$1.19B72.604,500News CoveragePositive NewsAnalyst ForecastGKOSGlaukos4.782 of 5 stars$95.86-0.7%$127.42+32.9%-29.8%$5.50B$383.48M-58.10780Positive NewsIRTCiRhythm Technologies1.5995 of 5 stars$169.98-0.9%$163.82-3.6%+141.4%$5.46B$591.84M-58.012,000BLCOBausch + Lomb2.2143 of 5 stars$14.63+0.6%$15.56+6.3%-9.8%$5.18B$4.79B-18.7613,500TMDXTransMedics Group3.1855 of 5 stars$114.96-1.5%$123.00+7.0%-33.6%$3.92B$441.54M59.57210Positive NewsGap DownSLNOSoleno Therapeutics4.5621 of 5 stars$67.67-1.1%$115.09+70.1%+37.3%$3.60BN/A-16.3530Positive News Related Companies and Tools Related Companies PHG Alternatives ZBH Alternatives SNN Alternatives SOLV Alternatives PEN Alternatives GKOS Alternatives IRTC Alternatives BLCO Alternatives TMDX Alternatives SLNO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:STVN) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stevanato Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
